Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2

Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2

US Patent 11833211 · Granted Dec 5, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic peptide ligands specific for PD-L12025
Bicyclic peptide ligands specific for Nectin-42025
Bicyclic peptide ligands specific for PSMA2025
Multimeric bicyclic peptide ligands2025
Bicyclic peptide ligands specific for MT1-MMP2025
Bicyclic peptide ligands specific for CD1372024
Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)2024
Modification of polypeptides2024
Bicyclic peptide ligands specific for nectin-42024
Bicyclic peptide ligands specific for nectin-42024
Bicyclic peptide ligands specific for TREM22024
Bicyclic peptide ligands specific for TSLP2024